The Reteplase Project Management Research Of FDZJ Stock Co.Ltd.

In this article, we give an exhaustive analysis on the management status quo of the Retapase Project, a Biopharmaceutics Project of FDZJ Company, and point out various weaknesses in its management that need to be improved. The market occupation of Retapase Project has been over appraised and the market orientation is based on self-reference while less weight has been put on market survey; The project fund comes inadequately from self-raised resources or by transferring the techniques. In the organization framework of the project, the conventional linear system is adopted, which inhibit imbibing the wisdom of majority; On personnel management, the R&D professionals have been weighed much more against the management professionals and little effort has been put on building the professionals reservoir, while the personnel incentive tactics are not conducive to the long benefit of the project In addition, the cost management is maldeveloped and the project progress controlling has been neglected.Based on the above-mentioned analysis, we use the theoretical knowledge of project management to elaborate the various possibilities to resolve the problems, and then put forward effective countermeasures, which include analyzing the competition strength of Retapase in the biopharmaceutical industry; evaluating the resources of the FDZJ company and its competition strength by using the SWOT analysis method, collecting the market information by questionnaire survey,interview and document retrieval of domestic and internal literatures.After this, we predict the market requirement and the price of the Rctapasc and propose to set up a project management team which can control the R&D, production, sales, finance and affair communicating personnel systematically. We also suggest to take the incentive mechanism of stock and future privilege to bind the benefit of personnel and that of projects together by adopting the structure of strong matrix and assembling the superiority of the linear system and that of the functional system. Furthermore, we suggest that the investment amount needed by the project should be evaluated in advance and investment capitals on stake should be attracted as much as possible to attenuate the risk of financing.In this article, we newly put forward a Gante Map of Relapse Project progress plan and help to realize the uniform management of Project R&D, production andsales, which can be expected to provide assistance and reference to the practical performance of Biopharmaceutical Projects.